FDA Greenlights Emergency Generic Drug to Halt New World Screwworm in Cattle

Translate text to Spanish or other 102 languages!

- Advertisement -
The U.S. Food and Drug Administration today issued an Emergency Use Authorization (EUA) for Bimectin (ivermectin) injection for the prevention of New World screwworm (NWS) infestations (myiasis) in cattle when administered within 24 hours of birth, at the time of castration, or at the appearance of a wound. Image for illustration purposes
The U.S. Food and Drug Administration today issued an Emergency Use Authorization (EUA) for Bimectin (ivermectin) injection for the prevention of New World screwworm (NWS) infestations (myiasis) in cattle when administered within 24 hours of birth, at the time of castration, or at the appearance of a wound. Image for illustration purposes
- Advertisement -

Food and Drug Administration (FDA)

The U.S. Food and Drug Administration has issued an Emergency Use Authorization (EUA) for Bimectin (ivermectin) injection for the prevention of New World screwworm (NWS) infestations (myiasis) in cattle when administered within 24 hours of birth, at the time of castration, or at the appearance of a wound – advancing the Trump Administration’s goal of safeguarding American agriculture from NWS. Bimectin injection is not authorized for use in lactating dairy cows or in calves that will be processed for veal.  

“This authorization reflects the FDA’s commitment to expanding generic drug options against New World screwworm,” said Timothy Schell, Ph.D., director of the FDA’s Center for Veterinary Medicine. “By authorizing both generic and pioneer products, the Agency is ensuring producers aren’t dependent on a single manufacturer or product to protect their herds.”

- Advertisement -

To maintain the continued safety of the food supply and avoid drug residues, it is critical that cattle producers carefully follow the 35-day slaughter withdrawal time and not administer this drug in lactating dairy cows and calves that will be processed for veal. 

Based on the totality of the scientific evidence available, the FDA has concluded it is reasonable to believe that Bimectin injection may be effective for the prevention of NWS myiasis in certain cattle when used as authorized, and the known and potential benefits of the product outweigh its known and potential risks. 

Bimectin injection is a generic version of Ivomec, which was authorized in February 2026 for the prevention of NWS myiasis in cattle. The FDA previously approved Bimectin injection for the treatment and control of various parasites in cattle. This EUA is only for the Bimectin injection and does not authorize other dosage forms of Bimectin.

Bimectin injection is available over the counter without a prescription. Cattle producers are responsible for using Bimectin injection in accordance with the product labeling and fact sheet.

- Advertisement -

This EUA will be effective until it is revoked or the HHS Secretary terminates the declaration that the potential public health emergency presented by NWS justifies the emergency use authorization of animal drugs for NWS.

Bimectin injection is sponsored by Bimeda Animal Health Ltd. based in Ireland.

Information source: Food and Drug Administration (FDA)

- Advertisement -
- Advertisement -
- Advertisement -

Latest News

More Articles Like This

- Advertisement -